Atrial Ca2+/calmodulin-dependent Protein Kinase-II: a Druggable Master Switch of Atrial Fibrillation-Associated Atrial Remodeling?

Dr. Dobrev is on the Scientific Advisory Board of OMEICOS and ACESION and received speaker ’s fees for educational lectures from Boston Scientific, Novartis, and Bristol Myers Squibb.

Source: Heart Rhythm - February 5, 2019 Category: Cardiology Authors: Dobromir Dobrev Source Type: research